Tae-Ho Hwang
Corporate Officer/Principal at Pusan National University
Tae-Ho Hwang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Pusan National University | Corporate Officer/Principal | - | - |
Pusan National University Hospital
 Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Corporate Officer/Principal | - | - |
Career history of Tae-Ho Hwang
Former positions of Tae-Ho Hwang
| Companies | Position | Start | End |
|---|---|---|---|
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
| Dong-A University | Corporate Officer/Principal | - | - |
| SILLAJEN, INC. | Chief Tech/Sci/R&D Officer | 01/05/2003 | - |
| Founder | 23/03/2006 | - |
Training of Tae-Ho Hwang
| Pusan National University | Doctorate Degree |
Statistics
International
| South Korea | 5 |
| United States | 3 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SILLAJEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Pusan National University Hospital
Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Health Services |
- Stock Market
- Insiders
- Tae-Ho Hwang
- Experience
